Form 8-K - Current report:
SEC Accession No. 0001140361-25-024348
Filing Date
2025-07-01
Accepted
2025-07-01 13:10:16
Documents
14
Period of Report
2025-07-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20051438_8k.htm   iXBRL 8-K 33657
2 EXHIBIT 99.1 ef20051438_ex99-1.htm EX-99.1 11006
6 image00001.jpg GRAPHIC 2574
  Complete submission text file 0001140361-25-024348.txt   185364

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA prok-20250701.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE prok-20250701_lab.xml EX-101.LAB 22690
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prok-20250701_pre.xml EX-101.PRE 16554
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20051438_8k_htm.xml XML 4398
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 251095276
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)